军事知识服务平台
PRMT6 is required for initiating and amplifying macrophage-induced inflammation in heterotopic ossification by increasing CCL2 expression
摘要 Heterotopic ossification(HO)is a debilitating disorder marked by ectopic bone formation in soft tissues,frequently triggered by inflammation after trauma.While macrophage-driven inflammation plays a critical role in HO pathogenesis,the molecular mechanisms governing its initiation,amplification and resolution remain elusive.Using a trauma/burn injury(TBI)-induced mouse model of HO,we identified rapid and sustained macrophage accumulation at the injury site during the early inflammatory phase,and macrophage depletion markedly suppressed HO formation.Transcriptomic profiling identified a pronounced upregulation of protein arginine methyltransferase 6(PRMT6)in macrophages following injury.Genetic deletion or macrophage-targeted knockdown of Prmt6 reduced macrophage accumulation and significantly attenuated HO,without impairing tendon repair.Consistently,pharmacological inhibition of PRMT6 suppressed HO only when administered during the early inflammatory phase,indicating a restricted therapeutic window.Mechanistically,PRMT6 amplified macrophage chemotactic signaling by transcriptionally and epigenetically upregulating CCL2.Genetic disruption of macrophage-derived CCL2 phenocopied Prmt6 deficiency,whereas CCL2 supplementation rescued macrophage recruitment and partially restored HO in Prmt6-deficient mice.At the molecular level,PRMT6 formed a coactivation complex with NF-κB and catalyzed H3R17 asymmetric dimethylation at the Ccl2 promoter,thereby promoting sustained chemokine expression.Collectively,our findings identify PRMT6 as a central epigenetic amplifier of macrophage-driven inflammation that links early injury responses to ectopic bone formation.Targeting PRMT6 during the early inflammatory phase represents a promising strategy to prevent HO while preserving physiological tissue repair.
年,卷(期): 2026, 14(2)
机标分类号: TP391.78 S S965.334
在线出版日期: 2026年5月18日